TL have you just found the answer for the delay of the announcement with the second largest mass market player.
If your theory is right and J+J having offloaded Janssen Pharmaceuticals (owner of Retin-A Micro for acne, Ertaczo for athlete’s foot and Renova, another acne treatment) as part of its ongoing efforts to restructure itself after a pretty ordinary time of it of late including 25 product recalls, is now to focus on lower risk (aka less prescription based) revenues which subsequently shifts focus to TPM - you may have just found the answer for the delay in the POH's announcement of the mass market player if this article has anything to do with it -
http://www.ftc.gov/os/caselist/1110216/111209valeantjjagree.pdf
Essentially the Janssen sale is being delayed by the federal trade commission. POH may just be under orders to hold off until the dust has settled before J+J roll with a new non-prescription based product.
- Forums
- ASX - By Stock
- j & j eats itself
TL have you just found the answer for the delay of the...
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
-0.001(20.0%) |
Mkt cap ! $6.338M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.2¢ | $68.62K | 33.31M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
41 | 36020232 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 43250695 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
41 | 36020232 | 0.002 |
17 | 76595009 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 43000695 | 23 |
0.004 | 15020712 | 15 |
0.005 | 22033532 | 10 |
0.006 | 19255067 | 9 |
0.007 | 5722471 | 6 |
Last trade - 13.47pm 09/09/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |